PT Suparma Tbk (IDX:SPMA)
Indonesia
· Delayed Price · Currency is IDR 216.00
-2.00 (-0.92%)
Apr 28, 2026, 4:00 PM WIB
PT Suparma Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 2,740,742 | 2,729,636 | 2,658,521 | 3,138,054 | 2,794,453 | Upgrade
|
| Revenue Growth (YoY) | 0.41% | 2.67% | -15.28% | 12.30% | 29.88% | Upgrade
|
| Cost of Revenue | 2,313,902 | 2,324,167 | 2,196,750 | 2,427,849 | 2,212,061 | Upgrade
|
| Gross Profit | 426,840 | 405,469 | 461,771 | 710,205 | 582,392 | Upgrade
|
| Selling, General & Admin | 221,602 | 209,905 | 206,708 | 183,723 | 169,709 | Upgrade
|
| Other Operating Expenses | 7,336 | 5,228 | - | 613.51 | - | Upgrade
|
| Operating Expenses | 228,938 | 215,133 | 206,708 | 184,337 | 169,709 | Upgrade
|
| Operating Income | 197,902 | 190,336 | 255,063 | 525,868 | 412,683 | Upgrade
|
| Interest Expense | -39,978 | -35,208 | -34,876 | -32,682 | -31,355 | Upgrade
|
| Interest & Investment Income | 6,336 | 7,541 | 5,809 | 4,247 | 1,344 | Upgrade
|
| Currency Exchange Gain (Loss) | -23,929 | -29,452 | 9,086 | -65,997 | 335.94 | Upgrade
|
| Other Non Operating Income (Expenses) | -3,593 | -3,424 | 3,042 | 632.25 | 3,373 | Upgrade
|
| EBT Excluding Unusual Items | 136,737 | 129,793 | 238,124 | 432,068 | 386,381 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 4,650 | -461.94 | -622.47 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 186.72 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -8,871 | Upgrade
|
| Pretax Income | 136,737 | 134,443 | 237,849 | 431,446 | 377,510 | Upgrade
|
| Income Tax Expense | 30,507 | 29,604 | 59,190 | 95,308 | 83,184 | Upgrade
|
| Net Income | 106,231 | 104,839 | 178,658 | 336,138 | 294,326 | Upgrade
|
| Net Income to Common | 106,231 | 104,839 | 178,658 | 336,138 | 294,326 | Upgrade
|
| Net Income Growth | 1.33% | -41.32% | -46.85% | 14.21% | 81.10% | Upgrade
|
| Shares Outstanding (Basic) | 4,100 | 4,100 | 4,100 | 4,100 | 4,100 | Upgrade
|
| Shares Outstanding (Diluted) | 4,100 | 4,100 | 4,100 | 4,100 | 4,100 | Upgrade
|
| EPS (Basic) | 25.91 | 25.57 | 43.57 | 81.98 | 71.78 | Upgrade
|
| EPS (Diluted) | 25.91 | 25.57 | 43.57 | 81.98 | 71.78 | Upgrade
|
| EPS Growth | 1.33% | -41.32% | -46.85% | 14.21% | 81.10% | Upgrade
|
| Free Cash Flow | 542,722 | 671,488 | 654,950 | 862,153 | 744,770 | Upgrade
|
| Free Cash Flow Per Share | 132.36 | 163.76 | 159.73 | 210.26 | 181.64 | Upgrade
|
| Dividend Per Share | - | - | 9.231 | - | - | Upgrade
|
| Gross Margin | 15.57% | 14.85% | 17.37% | 22.63% | 20.84% | Upgrade
|
| Operating Margin | 7.22% | 6.97% | 9.59% | 16.76% | 14.77% | Upgrade
|
| Profit Margin | 3.88% | 3.84% | 6.72% | 10.71% | 10.53% | Upgrade
|
| Free Cash Flow Margin | 19.80% | 24.60% | 24.64% | 27.47% | 26.65% | Upgrade
|
| EBITDA | 317,994 | 299,377 | 352,014 | 616,613 | 493,098 | Upgrade
|
| EBITDA Margin | 11.60% | 10.97% | 13.24% | 19.65% | 17.65% | Upgrade
|
| D&A For EBITDA | 120,092 | 109,041 | 96,951 | 90,745 | 80,415 | Upgrade
|
| EBIT | 197,902 | 190,336 | 255,063 | 525,868 | 412,683 | Upgrade
|
| EBIT Margin | 7.22% | 6.97% | 9.59% | 16.76% | 14.77% | Upgrade
|
| Effective Tax Rate | 22.31% | 22.02% | 24.89% | 22.09% | 22.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.